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Objective: To evaluate the Oxoid Toxin A test in comparison with a rapid cytotoxin method for the diagnosis of 
Clostridium difficile diarrhea in a UK tertiary referral hospital. 
Methods: One hundred previously tested samples were examined using a cytopathic effect (CPE) method and the Oxoid 
Toxin A test. Culture and toxin B titer measurement of the samples were performed to evaluate discrepancies between 
the tests. 
Results: The sensitivity and specificity of the Oxoid Toxin A test were 72% and 94%, respectively. This was similar to 
the CPE method read at 6 h: 67% and 94% in comparison. At 48 h, the sensitivity and specificity of the CPE method 
reached 98% and 100%. Toxigenic strains of C. difficile were cultured from 58 of 100 samples, and toxin was detected 
in 48 of 58. Following 4 weeks of storage at -2O"C, seven of 47 previously toxin B-positive stool filtrates had no detectable 
toxin. 
Conclusions: The Oxoid Toxin A test does not demonstrate a high enough sensitivity and specificity to be used as a 
primary test for C. difficile in hospitals where CPE testing is possible. Toxigenic strains of C. difficilecan be cultured from 
a significant number of samples where no toxins are detected. Toxin B titers in fecal samples and especially in stool 
filtrates, stored at -2O"C, diminish after thawing. 
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INTR OD U CTI 0 N 
The growing recognition of Clostvidium di@cile as a 
nosocomial pathogen [l-41 has led to a proliferation of 
commercial kits for the detection of the bacterium or 
its toxins. Antigen-detection kits for C. d f i c i l e  toxin A 
or toxins A and B obviate the need for cell-culture 
facilities. The kits also aim to provide a more rapid 
method for diagnosing C. d f i c i l e  infection than the 
standard cytopathic effect (CPE) tests using cell mono- 
layers, which conventionally require at least overnight 
incubation. In theory, obtaining a same-day test result 
may help in preventing the unnecessary use of specific 
antibiotic treatment for patients with diarrhea, and may 
reduce the spread of C. d f i c i l e  by ensuring that infected 
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patients are isolated, We aimed to determine the 
accuracy of one of these new rapid methods compared 
with a CPE method that was read at 4, 6, 24 and 48 h. 
We then sought to determine the reasons for any 
observed differences in results, using both C. d f i c i l e  
culture and measurement of toxin B titers in stool 
supernatants. 
MATERIALS AND METHODS 
We tested 100 stool samples that had been stored at 
- 20°C since original CPE testing, immediately after 
thawing. All samples were from patients with diarrheal 
illness where no other infective cause was identified, 
and 50 were previously cytotoxin positive while 50 
were previously negative. C. d f i c i l e  toxin detection was 
performed using both a CPE method and the Oxoid 
Toxin A test (Unipath, Basingstoke, UK). The prin- 
ciple of the test is that monoclonal toxin A antibody 
labeled with blue latex particles binds to any toxin A in 
the specimen when it is added to the sample well. The 
complex diffuses along the test strip and is bound to an 
immobilized line of toxin A monoclonal antibody, 
forming a blue line in a positive result. Immobilization 
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of unbound latex particles occurs in a second window 
to indicate that diffusion past the test window has 
occurred. The 100 samples were randomly arranged so 
that positives were indistinguishable from negatives. 
They were then thawed in batches of 10, and roughly 
0.5 g was suspended in the kit diluent or in 2 mL of 
phosphate-buffered saline (for the CPE test) (to a 
dilution of 1 in 5). The well-mixed suspensions were 
then centrifuged for 10 min at 12OOg, before being 
used for the kit test (according to the instructions), or 
kept in a refrigerator at 4°C (for <30 min) until the 
CPE test was set up. If the supernatants were cloudy 
following centrifugation, they were filtered through a 
0.45 millipore filter (Nalge, Rochester, NY, USA). 
C. d@le cytotoxin was detected by a modified 96- 
well microtiter tray (Life Technologies, Glasgow, UK) 
method [5], using HEp-2 cells with C. sordellii antitoxin 
(Pro-Lab Diagnostics, Bromborough, UK) protected 
controls, involving a further 1 in 10 dilution (20 (*.L of 
supernatant to 180 p,L of culture medium). Each batch 
of tests was controlled using a known positive super- 
natant (with and without C. sovdellii antitoxin), a well 
without any additions and a well with antitoxin only. 
The tests were incubated aerobically, in a wet box, at 
3 7 C ,  conditions under which no problems with the 
cell line have been encountered. Wells were examined 
for CPE at 4, 6, 24 and 48 h independently by two 
individuals. CPE consisted of a discernible, neutraliz- 
able rounding-up of cells, often quite subtle at 4 h and 
sometimes 6 h, but always affecting >lo% of cells 
initially and >50% of cells by 48 h. 
The stool samples were prepared for the Oxoid 
Toxin A test according to the manufacturer's instruc- 
tions. One  hundred and twenty-five microliters of 
supernatant was added to the sample window of the test 
strip. This was left for 30 min before being examined 
for any evidence of a blue line in the result window. 
Tests where the control window had a blue line and 
there was any sign of a blue line in the result window 
were classified as positive. 
All 100 specimens were cultured on cycloserine- 
cefoxitin egg yolk (CCEY) agar (Lab M, Bury, UK) [6] 
for 48 h in an anaerobic cabinet (Don Whitley 
Scientific, Shipley, UK) in an atmosphere of 80% Nz, 
10% H, and 10% CO., before being examined for C. 
d@cile. Isolates were recognized by typical colony 
appearance and characteristic odor. The toxigenicity of 
isolates cultured from fecal samples that were toxin 
negative by CPE was determined by CPE testing. 
Toxin-negative strains were then identified using the 
RapID ANAII kit (Innovative Diagnostics Systems, 
Norcross, Ga, USA). The supernatants used for CPE 
testing in this study were frozen at -20°C immediately 
after the cytotoxin test was set up. Cytotoxin titers were 
determined in these samples after 4 weeks, due to time 
constraints at the time of initial cytotoxin testing. They 
were tested for CPE neat (1 in 50 dilution) and at seven 
further 10-fold dilutions. The toxin titer was designated 
as the highest dilution which caused a readily 
discernible, classical CPE at 48 h (although in a few 
cases, at the highest dilution, these changes did not 
quite affect 50% of the total cells). 
RESULTS 
We found 53 samples to be CPE negative and 47 to be 
CPE positive (Table 1). Sensitivities and specificities 
are calculated using the CPE result at 48 h as the 
standard (with the addition of a sample which was 
Oxoid toxin A test positive, CPE negative, but culture 
positive for toxigenic C. d f i c i l e  as a true positive). By 
comparison, the Oxoid Toxin A kit produced 13 false- 
negative results (sensitivity 72%) and three false 
positives (specificity 94%), although it did detect toxin 
A in one specimen which was CPE test negative. A 
strain of C. dficile was cultured from this specimen and 
found to be cytotoxin positive (Table 1 and 2). 
There was a high degree of correlation (100% 
agreement at 48 h) between the two individuals who 
read the CPE test. At 6 h,  one investigator (the more 
experienced of the two) identified three additional 
positive specimens, one of which proved to be a false 
positive. 
Table 1 Sensitivity and specificity of CPE test for toxin B 
at various time intervals and for Oxoid toxin A test 
False Fake 
test test 
negatives positives Sensitivity Specificity 
CPE at incubation 
times (h) 
4 21 5 54 90 
6 15 3 67 9'4 
24 3 0 92 1 uu 
48 1 0 98 100 
A test 13 3 72 94 
Oxoid toxin 
Table 2 Concordance table for Oxoid Toxin A test and 
Toxin B detection bv cvtopathic effect 
_______ 
Kit CPE +ve CPE -ve 
Positive 34 '4 
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In this study, all 47 CPE-positive samples were C. 
d@cile culture positive, while 12 of the CPE-negative 
feces were also culture positive. Of these 12 strains, all 
but one was toxigenic by CPE testing. After storage of 
fecal supernatants at  -20°C for 4 weeks, C. df ic i le  
cytotoxin titers were found to range between 50 and at 
least 5 X 10'. In seven supernatants that were previously 
CPE positive, no cytotoxin was detected at this time. 
There were 11 samples with cytotoxin titers > lo3, and 
all were toxin A kit-test positive. One toxin A kit 
positive sample had a titer of only 1. No toxin A kit- 
negative samples had titers >lo3. 
DISCUSS I0 N 
The study demonstrates that the rapid kit test studied 
had a similar accuracy to our CPE method at 6 h, with 
a sensitivity and specificity of 72% and 94% versus 67% 
and 94%. respectively. These results differ from another 
assessment of the Oxoid toxin A kit by Bentley et al in 
1998 [7]. By 24 h, the sensitivity and specificity of the 
CPE method reach 92% and 100% respectively. The 
interesting observation that one sample was toxin A kit 
test positive but CPE test negative could be due to 
unequal rates of breakdown of the two toxins. The 
great majority of C. dificile strains produce equimolar 
quantities of toxins A and B [8]. The C. dlfficile culture 
results indicate that it is possible for a toxigenic strain 
of C. df ic i le  to be present in a sample and yet for toxins 
A and B to remain undetectable. This could be due to 
proteolytic degradation of toxins in the fecal sample, or 
lack of production of toxins in the bowel, possibly 
secondary to antimicrobial therapy, or toxin inhibitory 
effects of bowel flora. Theoretically, this effect could 
also be seen if the sample contained only C. df ic i le  
spores in small numbers. 
Some toxin A-positive samples had low cytotoxin 
titers, which may be because the greater stability of 
toxin A [9,10] resulted in more of it remaining in the 
sample than cytotoxin. There was an apparent correl- 
ation between cytotoxin titer and toxin A kit test 
positivity, as previously described for an ELISA 
method [11]. Other workers have reported no 
correlation between cytotoxin titer in samples and EIA 
readings [12]. The reliable threshold for toxin A 
detection in the present study appeared to be a titer of 
2 lo4. Cytotoxin in stool specimens and particularly in 
stool filtrates may deteriorate when these are thawed, 
after being stored at -2O"C, as previously noted [13]. 
The fact that some samples had no detectable toxin but 
did contain toxigenic organisms suggests that culture 
of toxigenic organisms alone from a sample may not 
automatically justi@ the treatment of a patient for C. 
d@cile infection. 
In this study, the sensitivity and specificity claimed 
in the kit insert by the manufacturer were not achieved 
(72% versus 90% and 94% versus 98%, respectively). 
However, the manufacturer's sensitivity figures were 
erroneously adjusted to classify cytotoxin-positive but 
culture-negative fecal samples as true kit negatives. The 
fact that detection of toxin A is not as sensitive as CPE 
methods that detect toxin B (and toxin A) is not 
surprising. Toxin B is extremely potent and can cause 
a cytopathic effect at concentrations as low as a few 
pg/mL, whereas the threshold of toxin A detection kits 
is in the ng/mL range [7]. 
It should also be emphasized that there are 
increasing reports of toxin A-negative, toxin B-positive 
(A-BS) C. di&n'le clinical isolates [10,14], and these 
will not be detected by toxin A kits [15-171. Brazier 
reported that C. dlfficile A-B+ isolates account for 3% 
of the total number of strains received from laboratories 
(but 10% of the strains submitted fiom one laboratory) 
in England and Wales by the Anaerobe Reference 
Laboratory [16]. While such strains appear to be 
uncommon in the USA [15], 33% of isolates collected 
in one hospital in Japan were of this phenotype [18]. 
As C. dlfficile A-B+ isolates have been recovered from 
symptomatic patients [16,17], previously held beliefs 
that toxin A is the most important toxin in the 
pathogenesis of human antibiotic-associated diarrhea 
must be called into question. 
The CPE test is achievable by most large clinical 
microbiology laboratories when several samples per day 
require examination for C. dlfficile cytotoxin. Although 
the CPE method at 6 h performs slightly less well than 
the Oxoid kit, it is noticeably superior by 24 h. This 
leaves the decision as to whether an immediate result is 
preferable to a more accurate one after 24 h. While in 
severe cases an immediate result may be argued to be 
of value, in practice most of these patients will be 
isolated and treated empirically. In addition, with the 
use of a test with lower sensitivity and specificity, some 
patients will be misidentified as being negative and 
others will receive unnecessary therapy. It should be 
remembered that a significant number of patients with 
C. dlfficile toxin-positive diarrhea will respond to 
withdrawal of antibiotics alone [19], and reacting to a 
very rapid test result may result in action before these 
patients declare themselves. The sensitivity of the CPE 
method may be improved if VERO cell lines are used. 
In our laboratory, testing around 5000 sampledyear by 
CPE, the cost per test (including technician time) is 
around 25p. This compares to a list price of A4 per test 
for the Oxoid toxin A test, excluding technician time. 
Furthermore, an increased number of repeat tests 
would be required if the Oxoid toxin A test was used. 
The Oxoid toxin A kit does not appear to be accurate 
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enough for use in primary diagnosis of C. d @ d e  
disease. It is interesting to note that the sensitivity of 
CPE testing for cytotoxin can reach 67% at 6 h. The 
CPE method can also be employed to test the 
toxigenicity of C. d@cile isolates directly from the 
culture plate. One  or two colonies of C. d@cile are 
emulsified in 0.5 mL of phosphate-buffered saline, 
which is then used in the same way as a stool filtrate in 
the CPE test, with results typically being readable after 
3-4 h of incubation (Settle and Wilcox, unpublished 
data). Rapid kit tests are more suited to situations 
where tests are infrequent, or cell-culture facilities are 
not available (although a virology laboratory is not 
essential for cell culture to be performed), but greater 
sensitivity than that demonstrated by this kit is required. 
In summary, the accuracy of the Oxoid toxin A test 
is not high enough for routine use in practice. Reduced 
sensitivity of the toxin A method may be due to 
specimens with low toxin titers being present. Toxin A 
levels may not decrease as quickly as toxin B levels, 
and specimens may be C. df ic i le  culture positive but yet 
contain no detectable toxin A or B, even though the 
strain is toxigenic. Cytotoxin levels fall in samples, and 
particularly supernatants, that are frozen and thawed. 
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